Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Liver Function Tests Explained: ALT, AST, Bilirubin, and What They Really Mean
Jan, 28 2026
Top 10 Online Pharmacy Alternatives to CanadaDrugsDirect for Affordable Medication
Dec, 19 2024
Age-Related Macular Degeneration: How Central Vision Loss Happens and How Anti-VEGF Treatments Help
Jan, 12 2026
Chinese Generic Production: Manufacturing and Quality Concerns in 2026
Jan, 10 2026
Retinal Vein Occlusion: Risk Factors and Injections Explained
Mar, 4 2026